Rabbit Recombinant Monoclonal ACSL6/ACS2 antibody. Carrier free. Suitable for WB, IP and reacts with Recombinant fragment - Human, Human, Mouse, Rat samples.
pH: 7.2 - 7.4
Constituents: 100% PBS
WB | IP | IHC-P | ICC/IF | |
---|---|---|---|---|
Human | Tested | Tested | Not recommended | Not recommended |
Mouse | Tested | Expected | Not recommended | Not recommended |
Rat | Tested | Expected | Not recommended | Not recommended |
Recombinant fragment - Human | Tested | Not recommended | Not recommended | Not recommended |
Species | Dilution info | Notes |
---|---|---|
Species Recombinant fragment - Human, Human, Mouse, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Recombinant fragment - Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse, Rat, Recombinant fragment - Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse, Rat, Recombinant fragment - Human | Dilution info - | Notes - |
Catalyzes the conversion of long-chain fatty acids to their active form acyl-CoA for both synthesis of cellular lipids, and degradation via beta-oxidation (PubMed:22633490, PubMed:24269233). Plays an important role in fatty acid metabolism in brain and the acyl-CoAs produced may be utilized exclusively for the synthesis of the brain lipid.
ACS2, FACL6, KIAA0837, LACS5, Long-chain-fatty-acid--CoA ligase 6, Arachidonate--CoA ligase, Long-chain acyl-CoA synthetase 6, LACS 6
Rabbit Recombinant Monoclonal ACSL6/ACS2 antibody. Carrier free. Suitable for WB, IP and reacts with Recombinant fragment - Human, Human, Mouse, Rat samples.
pH: 7.2 - 7.4
Constituents: 100% PBS
ab317704 is the carrier-free version of Anti-ACSL6/ACS2 antibody [EPR29174-76] ab317703.
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. The carrier-free buffer and high concentration allow for increased conjugation efficiency.
This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
The ACSL6 also known as ACS2 is an enzyme involved in lipid metabolism. It is responsible for converting long-chain fatty acids into acyl-CoA an essential step in the metabolism of fatty acids. ACSL6 has a molecular mass that ranges around 78 kilodaltons. It is expressed in the brain particularly in neurons and can also be found in other tissues like the heart and skeletal muscles. This enzyme is important for maintaining energy balance and proper neural function due to its role in lipid metabolism.
The activation of long-chain fatty acids by ACSL6 is an important step facilitating their incorporation into cellular lipids or their oxidation to generate energy. While ACSL6 does not form part of a multi-protein complex its activity aids in the regulation of lipidic composition within membranes and signaling molecules. ACSL6 plays a role in the maintenance of membrane fluidity which is important for neuronal health and function.
The role of ACSL6 in the metabolism of fatty acids intersects with the beta-oxidation and lipid biosynthesis pathways. ACSL6 cooperates with other ACSL family members such as ACSL1 in these pathways though each family member may have different substrate specificities. Fatty acid oxidation represents an important energy source especially in tissues with high demand like the heart and brain where ACSL6 is notably expressed.
Disruptions in ACSL6 activity have been associated with neurological disorders and metabolic diseases. For example aberrations in ACSL6 expression or function have been linked to schizophrenia where altered lipid metabolism may affect neural cell membranes and signaling. ACSL6's connection to schizophrenia involves interactions with pathways also influenced by proteins like COMT which is implicated in cognitive functions and neurochemistry. Such links suggest that ACSL6's proper functioning is necessary for maintaining normal physiological conditions in the brain and perhaps in associated metabolic contexts.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
This data was developed using Anti-ACSL6/ACS2 antibody [EPR29174-76] ab317703, the same antibody clone in a different buffer formulation.
ACSL6/ACS2 was immunoprecipitated from 0.35 mg Jurkat (human T cell leukemia T lymphocyte from peripheral blood) whole lysate with Anti-ACSL6/ACS2 antibody [EPR29174-76] ab317703 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using Anti-ACSL6/ACS2 antibody [EPR29174-76] ab317703 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(VeriBlot for IP Detection Reagent (HRP) ab131366) was used at 1/5000 dilution.
Lane 1: Jurkat (human T cell leukemia T lymphocyte from peripheral blood) whole lysate
Lane 2: Anti-ACSL6/ACS2 antibody [EPR29174-76] ab317703 IP in Jurkat (human T cell leukemia T lymphocyte from peripheral blood) whole lysate
Lane 3: Rabbit monoclonal IgG (Rabbit IgG, monoclonal [EPR25A] - Isotype Control ab172730) instead of Anti-ACSL6/ACS2 antibody [EPR29174-76] ab317703 in Jurkat whole cell lysate
Blocking and dilution buffer and concentration: 5% NFDM/TBST
This blot was developed using a high sensitivity ECL substrate. The high-sensitivity ECL substrate used allows for the detection of proteins in the mid-femtogram range.
All lanes: Immunoprecipitation - Anti-ACSL6/ACS2 antibody [EPR29174-76] (Anti-ACSL6/ACS2 antibody [EPR29174-76] ab317703) at 1/30 dilution
All lanes: Jurkat (human T cell leukemia T lymphocyte from peripheral blood) whole lysate
All lanes: Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (VeriBlot for IP Detection Reagent (HRP) ab131366) at 1/5000 dilution
Developed using the ECL technique.
Exposure time: 180s
This data was developed using Anti-ACSL6/ACS2 antibody [EPR29174-76] ab317703, the same antibody clone in a different buffer formulation.
Low expression: liver, lung (PMID: 12767919, PMID: 10502316).
The identity of the band at approximately 37 kDa (in lane 4) is unknown.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (Anti-GAPDH antibody [EPR16891] - Loading Control ab181602) staining at 1/200000 dilution.
All lanes: Western blot - Anti-ACSL6/ACS2 antibody [EPR29174-76] (Anti-ACSL6/ACS2 antibody [EPR29174-76] ab317703) at 1/1000 dilution
Lane 1: Human hypothalamus tissue lysate at 50 µg with NFDM/TBST
Lane 2: Human cerebellum tissue lysate at 50 µg with NFDM/TBST
Lane 3: Human lung tissue lysate at 50 µg with NFDM/TBST
Lane 4: Human liver tissue lysate at 50 µg with NFDM/TBST
All lanes: Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Observed band size: 74 kDa, 36 kDa
Exposure time: 180s
This data was developed using Anti-ACSL6/ACS2 antibody [EPR29174-76] ab317703, the same antibody clone in a different buffer formulation.
Low expression: liver, kidney (PMID: 12767919, PMID: 10502316).
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (Anti-GAPDH antibody [EPR16891] - Loading Control ab181602) staining at 1/200000 dilution.
All lanes: Western blot - Anti-ACSL6/ACS2 antibody [EPR29174-76] (Anti-ACSL6/ACS2 antibody [EPR29174-76] ab317703) at 1/1000 dilution
Lane 1: Rat brain tissue lysate at 20 µg with NFDM/TBST
Lane 2: Rat liver tissue lysate at 20 µg with NFDM/TBST
Lane 3: Mouse brain tissue lysate at 20 µg with NFDM/TBST
Lane 4: Mouse hypothalamus tissue lysate at 20 µg with NFDM/TBST
Lane 5: Mouse kidney tissue lysate at 20 µg with NFDM/TBST
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/100000 dilution
Developed using the ECL technique.
Observed band size: 74 kDa, 36 kDa
Exposure time: 180s
This data was developed using Anti-ACSL6/ACS2 antibody [EPR29174-76] ab317703, the same antibody clone in a different buffer formulation.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (Anti-GAPDH antibody [EPR16891] - Loading Control ab181602) staining at 1/200000 dilution.
All lanes: Western blot - Anti-ACSL6/ACS2 antibody [EPR29174-76] (Anti-ACSL6/ACS2 antibody [EPR29174-76] ab317703) at 1/1000 dilution
All lanes: Jurkat (human T cell leukemia T lymphocyte from peripheral blood) whole cell lysate at 20 µg with NFDM/TBST
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution
Observed band size: 74 kDa, 36 kDa
Exposure time: 180s
This data was developed using Anti-ACSL6/ACS2 antibody [EPR29174-76] ab317703, the same antibody clone in a different buffer formulation.
This antibody does not cross-react with human ACSL1 and ACSL5.
In Western blot, Anti-6X His tag® antibody [EPR20547] - ChIP Grade (Anti-6X His tag® antibody [EPR20547] - ChIP Grade ab213204) staining at 1/5000 dilution.
In Western blot, Anti-GST antibody [EPR4236] (Anti-GST antibody [EPR4236] ab111947) staining at 1/1000 dilution.
All lanes: Western blot - Anti-ACSL6/ACS2 antibody [EPR29174-76] (Anti-ACSL6/ACS2 antibody [EPR29174-76] ab317703) at 1/1000 dilution
Lane 1: His-tagged human ACSL6/ACS2 fragment at 10 ng with NFDM/TBST
Lane 2: GST-tagged human ACSL5 fragment at 10 ng with NFDM/TBST
Lane 3: His-tagged human ACSL1 fragment at 10 ng with NFDM/TBST
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/100000 dilution
Observed band size: 15 kDa, 37 kDa
Exposure time: 180s
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com